Please enable JavaScript to continue using this application.

Compare $COAG vs $TYRA | Chartloom

Compare

$COAG vs $TYRA

Hemab Therapeutics Holdings Inc · Tyra Biosciences Inc

COAG

Hemab Therapeutics Holdings Inc

TYRA

Tyra Biosciences Inc

Compare $COAG vs $TYRA

Comparing Hemab Therapeutics Holdings Inc and Tyra Biosciences Inc

COAGHemab Therapeutics Holdings Inc

TYRATyra Biosciences Inc

COAGHemab Therapeutics Holdings Inc

Market cap

$1.48B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-7.0%

52W performance

-7.0%

FCF yield

0.0%

TYRATyra Biosciences Inc

Market cap

$1.19B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-25.6%

52W performance

46.3%

FCF yield

-9.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COAG

TYRA

Detailed metrics comparison

COAG

Hemab Therapeutics Holdings Inc

TYRA

Tyra Biosciences Inc

Market Cap

COAG$1.48B

TYRA$1.19B

Enterprise Value

COAG$1.24B

TYRA$1.11B

Price

COAG$31.62

TYRA$19.94

P/E Ratio

COAGN/A

TYRAN/A

P/S Ratio

COAG0.00x

TYRA0.00x

EV/Sales

COAG0.00x

TYRA0.00x

EV/EBITDA

COAG0.00x

TYRA0.00x

P/B Ratio

COAG3.20x

TYRA3.97x

P/FCF Ratio

COAGN/A

TYRAN/A

EV/FCF

COAG0.00x

TYRA-10.12x

PEG Ratio

COAGN/A

TYRAN/A

Forward P/E (NTM)

COAGN/A

TYRAN/A

Forward P/S (NTM)

COAGN/A

TYRAN/A

Revenue (TTM)

COAG$0

TYRA$0

Revenue Growth (YoY)

COAGN/A

TYRAN/A

Forward Rev Growth

COAG1014.0%

TYRA680.8%

Gross Margin (TTM)

COAG0.0%

TYRA0.0%

Operating Margin (TTM)

COAG0.0%

TYRA0.0%

EBITDA Margin (TTM)

COAG0.0%

TYRA0.0%

Net Margin (TTM)

COAG0.0%

TYRA0.0%

FCF Margin (TTM)

COAGN/A

TYRAN/A

Net Income (TTM)

COAG$-47M

TYRA$-149M

FCF (TTM)

COAG$0

TYRA$-110M

EPS (TTM)

COAG-$1.00

TYRA-$2.25

ROE (TTM)

COAG0.0%

TYRA-4639.0%

ROA (TTM)

COAG0.0%

TYRA-4307.0%

ROIC (TTM)

COAG0.0%

TYRA-4639.0%

Cash

COAG$237M

TYRA$74M

Debt

COAG$0

TYRA$0

Net Cash/Debt

COAG$237M

TYRA$74M

Current Ratio (TTM)

COAG35.85x

TYRA14.91x

Quick Ratio (TTM)

COAG35.48x

TYRA14.48x

Debt/Equity (TTM)

COAG0.00x

TYRA0.00x

Debt/Assets (TTM)

COAG0.0%

TYRA0.0%

Interest Coverage (TTM)

COAGN/A

TYRAN/A

Net Debt/EBITDA (TTM)

COAG0.00x

TYRA0.00x

Beta

COAG-0.87

TYRA0.65

52W Performance

COAG-7.0%

TYRA46.3%

YTD Performance

COAG-7.0%

TYRA-25.6%

% from 52W High

COAG-42.9%

TYRA-50.9%

% from 52W Low

COAG37.5%

TYRA50.0%

Asset Turnover (TTM)

COAG0.00x

TYRA0.00x

FCF Yield (TTM)

COAG0.0%

TYRA-9.3%

Earnings Yield (TTM)

COAG-3.2%

TYRA-12.5%

Dividend Yield (TTM)

COAGN/A

TYRAN/A

Rule of 40

COAG0.0

TYRA0.0

EV/GP/RG

COAGN/A

TYRAN/A

Ticker research

View COAG research View TYRA research

Metric	COAG Hemab Therapeutics Holdings Inc	TYRA Tyra Biosciences Inc
Market & Valuation
Market Cap	$1.48B	$1.19B
Enterprise Value	$1.24B	$1.11B
Price	$31.62	$19.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.20x	3.97x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-10.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1014.0%	680.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-47M	$-149M
FCF (TTM)	$0	$-110M
EPS (TTM)	-$1.00	-$2.25
ROE (TTM)	0.0%	-4639.0%
ROA (TTM)	0.0%	-4307.0%
ROIC (TTM)	0.0%	-4639.0%
Financial Health
Cash	$237M	$74M
Debt	$0	$0
Net Cash/Debt	$237M	$74M
Current Ratio (TTM)	35.85x	14.91x
Quick Ratio (TTM)	35.48x	14.48x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.87	0.65
52W Performance	-7.0%	46.3%
YTD Performance	-7.0%	-25.6%
% from 52W High	-42.9%	-50.9%
% from 52W Low	37.5%	50.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-9.3%
Earnings Yield (TTM)	-3.2%	-12.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COAG research	View TYRA research

Valuation

P/S Ratio

COAG

0.00x

TYRA

0.00x

EV/FCF

TYRA

-10.12x

COAG

0.00x

Growth & revenue

Forward Revenue Growth

COAG

1014.0%

TYRA

680.8%

Profitability & performance

Gross Margin

COAG

0.0%

TYRA

0.0%

ROE

COAG

0.0%

TYRA

-4639.0%

FCF Yield %

COAG

0.0%

TYRA

-9.3%

52-Week Performance

TYRA

46.3%

COAG

-7.0%

Detailed metrics comparison

COAG

Hemab Therapeutics Holdings Inc

TYRA

Tyra Biosciences Inc

Market Cap

COAG$1.48B

TYRA$1.19B

Enterprise Value

COAG$1.24B

TYRA$1.11B

Price

COAG$31.62

TYRA$19.94

P/E Ratio

COAGN/A

TYRAN/A

P/S Ratio

COAG0.00x

TYRA0.00x

EV/Sales

COAG0.00x

TYRA0.00x

EV/EBITDA

COAG0.00x

TYRA0.00x

P/B Ratio

COAG3.20x

TYRA3.97x

P/FCF Ratio

COAGN/A

TYRAN/A

EV/FCF

COAG0.00x

TYRA-10.12x

PEG Ratio

COAGN/A

TYRAN/A

Forward P/E (NTM)

COAGN/A

TYRAN/A

Forward P/S (NTM)

COAGN/A

TYRAN/A

Revenue (TTM)

COAG$0

TYRA$0

Revenue Growth (YoY)

COAGN/A

TYRAN/A

Forward Rev Growth

COAG1014.0%

TYRA680.8%

Gross Margin (TTM)

COAG0.0%

TYRA0.0%

Operating Margin (TTM)

COAG0.0%

TYRA0.0%

EBITDA Margin (TTM)

COAG0.0%

TYRA0.0%

Net Margin (TTM)

COAG0.0%

TYRA0.0%

FCF Margin (TTM)

COAGN/A

TYRAN/A

Net Income (TTM)

COAG$-47M

TYRA$-149M

FCF (TTM)

COAG$0

TYRA$-110M

EPS (TTM)

COAG-$1.00

TYRA-$2.25

ROE (TTM)

COAG0.0%

TYRA-4639.0%

ROA (TTM)

COAG0.0%

TYRA-4307.0%

ROIC (TTM)

COAG0.0%

TYRA-4639.0%

Cash

COAG$237M

TYRA$74M

Debt

COAG$0

TYRA$0

Net Cash/Debt

COAG$237M

TYRA$74M

Current Ratio (TTM)

COAG35.85x

TYRA14.91x

Quick Ratio (TTM)

COAG35.48x

TYRA14.48x

Debt/Equity (TTM)

COAG0.00x

TYRA0.00x

Debt/Assets (TTM)

COAG0.0%

TYRA0.0%

Interest Coverage (TTM)

COAGN/A

TYRAN/A

Net Debt/EBITDA (TTM)

COAG0.00x

TYRA0.00x

Beta

COAG-0.87

TYRA0.65

52W Performance

COAG-7.0%

TYRA46.3%

YTD Performance

COAG-7.0%

TYRA-25.6%

% from 52W High

COAG-42.9%

TYRA-50.9%

% from 52W Low

COAG37.5%

TYRA50.0%

Asset Turnover (TTM)

COAG0.00x

TYRA0.00x

FCF Yield (TTM)

COAG0.0%

TYRA-9.3%

Earnings Yield (TTM)

COAG-3.2%

TYRA-12.5%

Dividend Yield (TTM)

COAGN/A

TYRAN/A

Rule of 40

COAG0.0

TYRA0.0

EV/GP/RG

COAGN/A

TYRAN/A

Ticker research

View COAG research View TYRA research

Metric	COAG Hemab Therapeutics Holdings Inc	TYRA Tyra Biosciences Inc
Market & Valuation
Market Cap	$1.48B	$1.19B
Enterprise Value	$1.24B	$1.11B
Price	$31.62	$19.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.20x	3.97x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-10.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1014.0%	680.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-47M	$-149M
FCF (TTM)	$0	$-110M
EPS (TTM)	-$1.00	-$2.25
ROE (TTM)	0.0%	-4639.0%
ROA (TTM)	0.0%	-4307.0%
ROIC (TTM)	0.0%	-4639.0%
Financial Health
Cash	$237M	$74M
Debt	$0	$0
Net Cash/Debt	$237M	$74M
Current Ratio (TTM)	35.85x	14.91x
Quick Ratio (TTM)	35.48x	14.48x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.87	0.65
52W Performance	-7.0%	46.3%
YTD Performance	-7.0%	-25.6%
% from 52W High	-42.9%	-50.9%
% from 52W Low	37.5%	50.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-9.3%
Earnings Yield (TTM)	-3.2%	-12.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COAG research	View TYRA research